Sergio Serrano-Villar

Cited by

	All	Since 2020
Citations	5513	3684
h-index	34	30
i10-index	84	67

820

410

205

615

201320142015201620172018201920202021202220232024202516 109 195 311 328 355 423 621 806 803 650 721 64

Public access

View all

84 articles

9 articles

available

not available

Based on funding mandates

Co-authors

Santiago MorenoHospital Ramón y Cajal, University of Alcala, MadridVerified email at salud.madrid.org
Vicente EstradaHospital Clinico San CarlosVerified email at salud.madrid.org
Javier Martínez-SanzInfectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.Verified email at salud.madrid.org
Jose A. Perez-MolinaNational Reference Center Tropical Imported Infections. ID Department. Hospital Universitario RamónVerified email at salud.madrid.org
Andres MoyaProfessor of Genetics, University of ValènciaVerified email at uv.es
Alejandro VallejoInvestigador Titular, Instituto Ramón y Cajal de Investigación Sanitaria (IRyCIS), HospitalVerified email at salud.madrid.org
Mª Ángeles Muñoz-FernándezHospital General Universitario Gregorio MarañónVerified email at salud.madrid.org
Coral BarbasUniversidad San Pablo-CEUVerified email at ceu.es
Matilde Sanchez CondeRamón y Cajal MadridVerified email at salud.madrid.org
Jorge F. Vázquez-CastellanosPostdoctoral Scientist, VIB - KU LeuvenVerified email at kuleuven.vib.be
Steven G. DeeksUniversity of California, San FranciscoVerified email at ucsf.edu
Peter HuntUniversity of California San FranciscoVerified email at php.ucsf.edu
Javier ZamoraHead of Clinical Biostatistics Unit. Hospital Ramon y Cajal (IRYCIS). CIBERESPVerified email at salud.madrid.org
Alfonso Muriel (https://orcid.org/0000-0...Hospital Universitario Ramon y Cajal (RoR:050eq1942). Universidad de Alcalá (RoR: 04pmn0e78)Verified email at uah.es
Amparo LatorreProfessor of Genetics, University of ValenciaVerified email at uv.es
Manuel FerrerInvestigador CientíficoVerified email at icp.csic.es
Alba Talavera-RodríguezInfectious Diseases Department IRYCIS (Ramón y Cajal Health Research Institute)Verified email at salud.madrid.org
Joseph M. McCuneProfessor of Medicine, University of California, San FranciscoVerified email at ucsf.edu
Félix Gutiérrez RoderoHospital Universitario de Elche & Universidad Miguel Hernández, Alicante, SpainVerified email at gva.es
Jana SeifertUniversity of HohenheimVerified email at uni-hohenheim.de

Sergio Serrano-Villar

Hospital Universitario Ramón y Cajal, Madrid

Verified email at salud.madrid.org

HIV infection Infectious Diseases Microbiome


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk … S Serrano-Villar, T Sainz, SA Lee, PW Hunt, E Sinclair, BL Shacklett, ... PLoS pathogens 10 (5), e1004078, 2014	692	2014
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... The lancet HIV 7 (8), e554-e564, 2020	432	2020
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ... Mucosal immunology 8 (4), 760-772, 2015	302	2015
Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ... PloS one 9 (1), e85798, 2014	267	2014
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ... Aids 30 (9), 1385-1392, 2016	242	2016
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults T Sainz, S Serrano-Villar, L Díaz, MIG Tomé, MD Gurbindo, MI de José, ... Aids 27 (9), 1513-1516, 2013	197	2013
The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery S Serrano‐Villar, S Moreno, M Fuentes‐Ferrer, C Sánchez‐Marcos, ... HIV medicine 15 (1), 40-49, 2014	194	2014
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression S Serrano-Villar, C Gutiérrez, A Vallejo, B Hernandez-Novoa, L Díaz, ... Journal of Infection 66 (1), 57-66, 2013	180	2013
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects S Serrano-Villar, JF Vázquez-Castellanos, A Vallejo, A Latorre, T Sainz, ... Mucosal immunology 10 (5), 1279-1293, 2017	136	2017
IL-15 promotes activation and expansion of CD8⁺ T cells in HIV-1 infection SA Younes, ML Freeman, JC Mudd, CL Shive, A Reynaldi, S Panigrahi, ... The Journal of clinical investigation 126 (7), 2745-2756, 2016	122	2016
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients I Iturrieta-Zuazo, CG Rita, A García-Soidán, A de Malet Pintos-Fonseca, ... Clinical immunology 219, 108572, 2020	116	2020
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study J Martínez-Sanz, A Muriel, R Ron, S Herrera, JA Pérez-Molina, S Moreno, ... Clinical Microbiology and Infection 27 (2), 238-243, 2021	114	2021
Gut bacteria metabolism impacts immune recovery in HIV-infected individuals S Serrano-Villar, D Rojo, M Martínez-Martínez, S Deusch, ... EBioMedicine 8, 203-216, 2016	114	2016
Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers OM Moreno‐Arrones, S Serrano‐Villar, V Perez‐Brocal, ... Journal of the European Academy of Dermatology and Venereology 34 (2), 400-405, 2020	104	2020
The impact of human immunodeficiency virus infection on gut microbiota α-diversity: an individual-level meta-analysis SA Tuddenham, WLA Koay, N Zhao, JR White, KG Ghanem, CL Sears Clinical Infectious Diseases 70 (4), 615-627, 2020	97	2020
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis JRP Pardo, SS Villar, JCR Ramos, V Pintado Enfermedades infecciosas y microbiologia clinica 32, 41-48, 2014	87	2014
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ... Nature Communications 12 (1), 1139, 2021	81	2021
Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men A Goren, CG Wambier, S Herrera, J McCoy, S Vaño‐Galván, F Gioia, ... Journal of the European Academy of Dermatology and Venereology 35 (1), e13, 2020	71	2020
Human immunodeficiency virus as a chronic disease: evaluation and management of nonacquired immune deficiency syndrome-defining conditions S Serrano-Villar, F Gutiérrez, C Miralles, J Berenguer, A Rivero, ... Open Forum Infectious Diseases 3 (2), ofw097, 2016	71	2016
Smoking cessation in HIV patients: rate of success and associated factors M Fuster, V Estrada, MC Fernandez‐Pinilla, ME Fuentes‐Ferrer, ... HIV medicine 10 (10), 614-619, 2009	70	2009

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors